Randomized, Single-blind Pilot Study Assessing the Effect of Cutaneous RESonance Stimulation SYMPAthetic and Parasympathetic Tone and Anxiety in Patients Admitted for Cardiac Surgery
RESC SYMPA
1 other identifier
observational
62
1 country
1
Brief Summary
Anxiety is a natural response to stress which peaks just before the surgery procedure. High levels of anxiety can increase postoperative pain and complications. Medicated anxiolysis is no longer recommended, in the absence of proven efficacy. Other interventions to prevent anxiety are required. The autonomic nervous system (ANS), both sympathetic and parasympathetic, determines the response to stress. Anxiety interventions such as hypnosis, massage and relaxation work by modulating ANS tone. The ANS also modulates heart rate. Anxiety can be measured by RR space, from which HRV, high-frequency (HF) and low-frequency (LF) are components respectively linked to the parasympathetic and sympathetic systems. The LF/HF ratio reflects sympathetic dominance if high, and parasympathetic dominance if low. Cutaneous resonance stimulation (RESC) is a manual technique. RESC can diagnose and correct energy imbalances by skin stimulation between two points and thus act on anxiety. We hypothesized that a preoperative RESC session would modify the sympathetic/parasympathetic balance and reduce anxiety in patients admitted for cardiac surgery, compared to patient receiving a sham RESC session: non-specific cutaneous stimulation (NSCS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 23, 2025
CompletedFirst Posted
Study publicly available on registry
July 17, 2025
CompletedStudy Start
First participant enrolled
September 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 3, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 3, 2027
December 19, 2025
December 1, 2025
1.4 years
June 23, 2025
December 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
LF/HF ratio variation compared between the groups
LF and HF will be monitored during the all RESC/NSCS.
Between the beginning and the end of the RESC/NCS session (20 minutes)
Secondary Outcomes (9)
Skin conductance variation compared between the groups
Between the beginning and the end of the RESC/NCS session (20 minutes)
Perfusion index variations compared between the groups.
Between the beginning and the end of the RESC/NCS session (20 minutes)
Analgesia nociception index compared between the groups
Between the beginning and the end of the RESC/NCS session (20 minutes)
Anxiety compared between the groups
After de RESC/NCS session
Morphine use post-surgery compared between the groups
Day 1
- +4 more secondary outcomes
Study Arms (2)
CUTANEOUS RESONANCE STIMULATION (RESC)
If randomized in the RESC group, interventional group, patient will receive a 20 minutes session of cutaneous resonance stimulation before his cardiac surgery according to a standardized protocol.
NON SPECIFIC CUTANEOUS STIMULATION (NSCS)
If randomized in the NSCS group, control group, patient will receive a 20 minutes session of non-specific cutaneous stimulation before his cardiac surgery according to a standardized protocol.
Interventions
If randomized in the RESC group, interventional group, patient will receive a 20 minutes session of cutaneous resonance stimulation before his cardiac surgery. He will be asked to respond to anxiety questionnaire STAI-E and to evaluate his anxiety on a visual analogue scale (VAS) at J-1 (day of inclusion), J0 (day of surgery), and J1 (the day after surgery). During the RESC session, LF/HF ratio, ANI, heart rate, respiratory rate, perfusion index and skin conductance will be monitored.
If randomized in the NSCS group, interventional group, patient will receive a 20 minutes session of non-specific cutaneous stimulation before his cardiac surgery. He will be asked to respond to anxiety questionnaire STAI-E and to evaluate his anxiety on a visual analogue scale at J-1 (day of inclusion), J0 (day of surgery), and J1 (the day after surgery) During the NSCS session, LF/HF ratio, ANI, heart rate, respiratory rate, perfusion index and skin conductance will be monitored.
Eligibility Criteria
Adult patients admitted for cardiac surgery with significant preoperative anxiety.
You may qualify if:
- Planned cardiac surgery with extracorporeal circulation
- Pre operatory anxiety : STAI-E score \>30 or Visual Analogue Scale Anxiety \>6
You may not qualify if:
- Urgent surgery
- Atrial fibrillation
- Impossibility to answer to STAI-E or VAS
- Use of alternative method
- Absence of consent
- Pregnant, breastfeeding women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopitallouis Pradel
Bron, 69500, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2025
First Posted
July 17, 2025
Study Start
September 30, 2025
Primary Completion (Estimated)
March 3, 2027
Study Completion (Estimated)
March 3, 2027
Last Updated
December 19, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share